The purpose of this open-label, pilot study is to evaluate fMRI as a biomarker of opioid
antagonism in adolescents with ED. Modulation of brain activation will be examined in regions
of interest by fMRI using a food-specific and general reward task in adolescents with ED in a
pre/post design.